2025 HCPCS Code Q2055
Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
TAGS: directed preparation maturation idecabtagene leukapheresis antigen autologous therapeutic million| Short Description | Idecabtagene vicleucel car |
| HCPCS Action Code | C - Change in long description of procedure or modifier code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2022 |
| HCPCS Action Effective Date | April 04, 2024 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4050 - Cast supplies unlisted
- Q4051 - Splint supplies misc
- Q4074 - Iloprost non-comp unit dose
- Q4081 - Epoetin alfa, 100 units esrd
- Q4082 - Drug/bio noc part b drug cap
- Q4100 - Skin substitute, nos
- Q4101 - Apligraf
- Q4102 - Oasis wound matrix
- Q4103 - Oasis burn matrix
- Q4104 - Integra bmwd
- Q4105 - Integra drt or omnigraft
- Q4106 - Dermagraft
- Q4107 - Graftjacket
- Q4108 - Integra matrix
- Q4110 - Primatrix
- Q4111 - Gammagraft
- Q4112 - Cymetra injectable
- Q4113 - Graftjacket xpress
- Q4114 - Integra flowable wound matri
- Q4115 - Alloskin